Concussion Alliance Interview

Written By John Hauschildt

Concussion Alliance Interviews the CEO of Oxeia,  Michael Wyand and co-founder and chief scientific officer, Dr. Vishal Bansal on the company’s work developing a drug treatment for concussion.

Read Part 1 | Read Part 2

John Hauschildt https://www.RumDoodle.com
Previous

News Release: Oxeia announces initiation of Phase 2 trial for OXE103
Next

New Treatment for Concussion with Dr. Bansal on Recovery Now with Kim Justus